Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Xanadu Quantum Technologies Stock Will Rally on Meeting Milestones, Monetizing, RBC Says

Xanadu Quantum Technologies Stock Will Rally on Meeting Milestones, Monetizing, RBC Says

MT newswireMT newswire2026/09/29 15:46
11:46 AM EDT, 09/29/2026 (MT Newswires) -- Xanadu Quantum Technologies' (XNDU) stock will rally as it meets more milestones and begins monetizing through quantum computing as a service, selling quantum hardware and other paths, RBC Capital Markets said in a note Monday. Analysts said that Xanadu provides investors with exposure to quantum computing, a generational opportunity and photonics, a "unique" modality. RBC said that while Xanadu still has several years before it can commercialize, it has already achieved key development milestones and has a path towards a fault-tolerant quantum data center. Analysts, however, noted difficulties with benchmark valuation as Xanadu has nominal near-term revenue. RBC initiated coverage on the stock with an outperform, speculative risk rating, and a $16 price target. Price: 4.90, Change: +0.13, Percent Change: +2.62
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21